255 related articles for article (PubMed ID: 32729662)
1. The phytochemical epigallocatechin gallate prolongs the lifespan by improving lipid metabolism, reducing inflammation and oxidative stress in high-fat diet-fed obese rats.
Yuan H; Li Y; Ling F; Guan Y; Zhang D; Zhu Q; Liu J; Wu Y; Niu Y
Aging Cell; 2020 Sep; 19(9):e13199. PubMed ID: 32729662
[TBL] [Abstract][Full Text] [Related]
2. The phytochemical, EGCG, extends lifespan by reducing liver and kidney function damage and improving age-associated inflammation and oxidative stress in healthy rats.
Niu Y; Na L; Feng R; Gong L; Zhao Y; Li Q; Li Y; Sun C
Aging Cell; 2013 Dec; 12(6):1041-9. PubMed ID: 23834676
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats.
Li W; Zhu C; Liu T; Zhang W; Liu X; Li P; Zhu T
Diab Vasc Dis Res; 2020; 17(6):1479164120966998. PubMed ID: 33280417
[TBL] [Abstract][Full Text] [Related]
4. Dietary supplementation with a low dose of (-)-epigallocatechin-3-gallate reduces pro-inflammatory responses in peripheral leukocytes of non-obese type 2 diabetic GK rats.
Uchiyama Y; Suzuki T; Mochizuki K; Goda T
J Nutr Sci Vitaminol (Tokyo); 2013; 59(6):541-7. PubMed ID: 24477251
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin gallate suppresses hepatic cholesterol synthesis by targeting SREBP-2 through SIRT1/FOXO1 signaling pathway.
Li Y; Wu S
Mol Cell Biochem; 2018 Nov; 448(1-2):175-185. PubMed ID: 29446047
[TBL] [Abstract][Full Text] [Related]
6. Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats.
Yang Z; Zhu MZ; Zhang YB; Wen BB; An HM; Ou XC; Xiong YF; Lin HY; Liu ZH; Huang JA
Phytother Res; 2019 Apr; 33(4):1019-1026. PubMed ID: 30746789
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate protects against the exacerbation of allergic eosinophilic inflammation associated with obesity in mice.
André DM; Horimoto CM; Calixto MC; Alexandre EC; Antunes E
Int Immunopharmacol; 2018 Sep; 62():212-219. PubMed ID: 30015241
[TBL] [Abstract][Full Text] [Related]
8. Effects of (-)-Epigallocatechin Gallate (EGCG) on Energy Expenditure and Microglia-Mediated Hypothalamic Inflammation in Mice Fed a High-Fat Diet.
Zhou J; Mao L; Xu P; Wang Y
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400620
[TBL] [Abstract][Full Text] [Related]
9. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice.
Santamarina AB; Carvalho-Silva M; Gomes LM; Okuda MH; Santana AA; Streck EL; Seelaender M; do Nascimento CM; Ribeiro EB; Lira FS; Oyama LM
J Nutr Biochem; 2015 Nov; 26(11):1348-56. PubMed ID: 26300331
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin gallate improves insulin resistance in HepG2 cells through alleviating inflammation and lipotoxicity.
Zhang Q; Yuan H; Zhang C; Guan Y; Wu Y; Ling F; Niu Y; Li Y
Diabetes Res Clin Pract; 2018 Aug; 142():363-373. PubMed ID: 29940201
[TBL] [Abstract][Full Text] [Related]
11. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice.
Bose M; Lambert JD; Ju J; Reuhl KR; Shapses SA; Yang CS
J Nutr; 2008 Sep; 138(9):1677-83. PubMed ID: 18716169
[TBL] [Abstract][Full Text] [Related]
12. Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice.
Chen YK; Cheung C; Reuhl KR; Liu AB; Lee MJ; Lu YP; Yang CS
J Agric Food Chem; 2011 Nov; 59(21):11862-71. PubMed ID: 21932846
[TBL] [Abstract][Full Text] [Related]
13. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
Lee MS; Kim CT; Kim Y
Ann Nutr Metab; 2009; 54(2):151-7. PubMed ID: 19390166
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of epigallocatechin gallate from green tea on oxidation and tissue incorporation of dietary lipids in mice fed a high-fat diet.
Friedrich M; Petzke KJ; Raederstorff D; Wolfram S; Klaus S
Int J Obes (Lond); 2012 May; 36(5):735-43. PubMed ID: 21750518
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin gallate prevents inflammation by reducing macrophage infiltration and inhibiting tumor necrosis factor-α signaling in the pancreas of rats on a high-fat diet.
Cao Y; Bao S; Yang W; Zhang J; Li L; Shan Z; Teng W
Nutr Res; 2014 Dec; 34(12):1066-74. PubMed ID: 25453543
[TBL] [Abstract][Full Text] [Related]
16. Dietary supplementation with (-)-epigallocatechin-3-gallate reduces inflammatory response in adipose tissue of non-obese type 2 diabetic Goto-Kakizaki (GK) rats.
Uchiyama Y; Suzuki T; Mochizuki K; Goda T
J Agric Food Chem; 2013 Nov; 61(47):11410-7. PubMed ID: 24206061
[TBL] [Abstract][Full Text] [Related]
17. N-Oleoyl-Phosphatidyl-Ethanolamine and Epigallo Catechin-3-Gallate Mitigate Oxidative Stress in Overweight and Class I Obese People on a Low-Calorie Diet.
Cazzola R; Rondanelli M
J Med Food; 2020 Mar; 23(3):319-325. PubMed ID: 31928490
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin Gallate Suppresses Inflammatory Responses by Inhibiting Toll-like Receptor 4 Signaling and Alleviates Insulin Resistance in the Livers of High-fat-diet Rats.
Hou H; Yang W; Bao S; Cao Y
J Oleo Sci; 2020 May; 69(5):479-486. PubMed ID: 32281563
[TBL] [Abstract][Full Text] [Related]
19. RNA-seq analysis of diet-driven obesity and anti-obesity effects of quercetin glucoside or epigallocatechin gallate in Drosophila adults.
Azuma M; Dat Le T; Yoshimoto Y; Hiraki N; Yamanaka M; Omura F; Inoue YH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):857-876. PubMed ID: 30720195
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin gallate improves insulin signaling by decreasing toll-like receptor 4 (TLR4) activity in adipose tissues of high-fat diet rats.
Bao S; Cao Y; Fan C; Fan Y; Bai S; Teng W; Shan Z
Mol Nutr Food Res; 2014 Apr; 58(4):677-86. PubMed ID: 24259392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
